These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38522572)

  • 41. In critically ill patients, B-type natriuretic peptide (BNP) and N-terminal pro-BNP levels correlate with C-reactive protein values and leukocyte counts.
    Rudiger A; Fischler M; Harpes P; Gasser S; Hornemann T; von Eckardstein A; Maggiorini M
    Int J Cardiol; 2008 May; 126(1):28-31. PubMed ID: 17477984
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association between serum n-terminal pro-brain natriuretic peptide concentration and left ventricular dysfunction and extracellular water in continuous ambulatory peritoneal dialysis patients.
    Lee JA; Kim DH; Yoo SJ; Oh DJ; Yu SH; Kang ET
    Perit Dial Int; 2006; 26(3):360-5. PubMed ID: 16722030
    [TBL] [Abstract][Full Text] [Related]  

  • 43. B-type (brain) natriuretic peptide and pruritus in hemodialysis patients.
    Shimizu Y; Sonoda A; Nogi C; Ogushi Y; Kanda R; Yamaguchi S; Nohara N; Aoki T; Yamada K; Nakata J; Io H; Kurusu A; Hamada C; Horikoshi S; Tomino Y
    Int J Nephrol Renovasc Dis; 2014; 7():329-35. PubMed ID: 25187733
    [TBL] [Abstract][Full Text] [Related]  

  • 44. B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: relationship to renal function and left ventricular hypertrophy.
    Vickery S; Price CP; John RI; Abbas NA; Webb MC; Kempson ME; Lamb EJ
    Am J Kidney Dis; 2005 Oct; 46(4):610-20. PubMed ID: 16183415
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effects of super-flux (high performance) dialyzer on plasma glycosylated pro-B-type natriuretic peptide (proBNP) and glycosylated N-Terminal proBNP in end-stage renal disease patients on dialysis.
    Nakagawa Y; Nishikimi T; Kuwahara K; Yasuno S; Kinoshita H; Kuwabara Y; Nakao K; Minami T; Yamada C; Ueshima K; Ikeda Y; Okamoto H; Horii K; Nagata K; Kangawa K; Minamino N; Nakao K
    PLoS One; 2014; 9(3):e92314. PubMed ID: 24667631
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic value of B-type natriuretic peptide and its amino-terminal proBNP fragment for cardiovascular events with stratification by renal function.
    Horii M; Matsumoto T; Uemura S; Sugawara Y; Takitsume A; Ueda T; Nakagawa H; Nishida T; Soeda T; Okayama S; Somekawa S; Ishigami K; Takeda Y; Kawata H; Kawakami R; Saito Y
    J Cardiol; 2013 Jun; 61(6):410-6. PubMed ID: 23618914
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interventions in the B-type natriuretic peptide signalling pathway as a means of controlling chronic itch.
    Meng J; Chen W; Wang J
    Br J Pharmacol; 2020 Mar; 177(5):1025-1040. PubMed ID: 31877230
    [TBL] [Abstract][Full Text] [Related]  

  • 48. B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide are depressed in obesity despite higher left ventricular end diastolic pressures.
    Taylor JA; Christenson RH; Rao K; Jorge M; Gottlieb SS
    Am Heart J; 2006 Dec; 152(6):1071-6. PubMed ID: 17161055
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effects of L-carnitine on serum levels of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide and cardiac function in children with severe hand-foot-mouth disease].
    Pan YZ; Song CL; Guo YJ; Wang LL; Cui YJ; Ren YF
    Zhongguo Dang Dai Er Ke Za Zhi; 2018 Aug; 20(8):635-640. PubMed ID: 30111472
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Neuropeptide Y Y
    Ma H; Gao T; Jakobsson JET; Weman HM; Xu B; Larhammar D; Lagerström MC
    J Pharmacol Exp Ther; 2020 Jan; 372(1):73-82. PubMed ID: 31771994
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of cardiac and renal function with extreme N-terminal fragment pro-B-type natriuretic peptide levels in elderly patients.
    Cui H; Huo G; Liu L; Fan L; Ye P; Cao J; Bai Y; Wang F; Hu Y
    BMC Cardiovasc Disord; 2012 Jul; 12():57. PubMed ID: 22834778
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay for the N-terminal fragment of the pro-peptide of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide.
    Prontera C; Emdin M; Zucchelli GC; Ripoli A; Passino C; Clerico A
    Clin Chem Lab Med; 2004 Jan; 42(1):37-44. PubMed ID: 15061378
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Natriuretic peptides in chronic kidney disease.
    Tagore R; Ling LH; Yang H; Daw HY; Chan YH; Sethi SK
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1644-51. PubMed ID: 18632852
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia.
    Sabatine MS; Morrow DA; de Lemos JA; Omland T; Desai MY; Tanasijevic M; Hall C; McCabe CH; Braunwald E
    J Am Coll Cardiol; 2004 Nov; 44(10):1988-95. PubMed ID: 15542281
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Only large reductions in concentrations of natriuretic peptides (BNP and NT-proBNP) are associated with improved outcome in ambulatory patients with chronic heart failure.
    Miller WL; Hartman KA; Grill DE; Burnett JC; Jaffe AS
    Clin Chem; 2009 Jan; 55(1):78-84. PubMed ID: 19028821
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical evaluation of capillary B-type natriuretic peptide testing.
    Schreinlechner M; Mrakovic A; Laschober G; Mayerl C; Griesmacher A; van Lippen L; Semjonow V; Nieuwenhuis J; van Reenen A; Mair J
    Clin Chem Lab Med; 2020 Mar; 58(4):618-624. PubMed ID: 31804953
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Usefulness of serial N-terminal pro-B-type natriuretic peptide measurements for determining prognosis in patients with pulmonary arterial hypertension.
    Mauritz GJ; Rizopoulos D; Groepenhoff H; Tiede H; Felix J; Eilers P; Bosboom J; Postmus PE; Westerhof N; Vonk-Noordegraaf A
    Am J Cardiol; 2011 Dec; 108(11):1645-50. PubMed ID: 21890089
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relationship between B-type natriuretic peptides and pulmonary capillary wedge pressure in the intensive care unit.
    Forfia PR; Watkins SP; Rame JE; Stewart KJ; Shapiro EP
    J Am Coll Cardiol; 2005 May; 45(10):1667-71. PubMed ID: 15893185
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Changes of natriuretic peptides predict hospital admissions in patients with chronic heart failure: a meta-analysis.
    Savarese G; Musella F; D'Amore C; Vassallo E; Losco T; Gambardella F; Cecere M; Petraglia L; Pagano G; Fimiani L; Rengo G; Leosco D; Trimarco B; Perrone-Filardi P
    JACC Heart Fail; 2014 Apr; 2(2):148-58. PubMed ID: 24720923
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Significance of NT-pro-BNP in acute exacerbation of COPD patients without underlying left ventricular dysfunction.
    Adrish M; Nannaka VB; Cano EJ; Bajantri B; Diaz-Fuentes G
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1183-1189. PubMed ID: 28458528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.